Literature DB >> 10601580

Bradykinin-induced inhibition of cell proliferation and tyrosine kinase activity in rat mesangial cells.

C Alric1, C Pecher, J P Schanstra, J L Bascands, J P Girolami.   

Abstract

The relationship between cell proliferation, protein tyrosine phosphorylation, phosphotyrosine kinase activity and bradykinin receptor activation in rat mesangial cells was investigated. We demonstrated that bradykinin (BK), through the B2 receptor, induced a dose-dependent inhibition of mesangial cell proliferation stimulated by fetal calf serum. We next found that BK induced a dose-dependent inhibition of phospho-tyrosine kinase activity. Treatments with pertussis-toxin, inhibition of phospholipase C and protein kinase C inhibitors and chelation of free cytosolic calcium did not change the bradykinin-induced inhibition of phosphotyrosine kinase. Western blot analysis of phosphotyrosinated proteins demonstrated that BK reduced tyrosine phosphorylation of several proteins among which we identified the 125-focal adhesion kinase. Taken together, these data suggest for the first time that, in proliferating rat mesangial cells, B2 receptor stimulation is able to induce, via a pertussis insensitive pathway, the inhibition of tyrosine kinase activity and mesangial cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10601580     DOI: 10.3892/ijmm.5.1.85

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  2 in total

1.  Cell survival signalling in heart derived myofibroblasts induced by preconditioning and bradykinin: the role of p38 MAP kinase.

Authors:  Marie Cooper; Kirsti Ytrehus
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

2.  Bradykinin B2 receptor null mice harboring a Ser23-to-Ala substitution in the p53 gene are protected from renal dysgenesis.

Authors:  Samir S El-Dahr; Karam Aboudehen; Susana Dipp
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.